MedMen Enterprises Inc.

Earnings data Q2 2020

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

MedMen Enterprises, Inc. engages in the manufacture and marketing of cannabis products. It operates through the following geographical segments: California, Illinois, Nevada, Arizona, and Massachusetts. The company was founded by Adam Bierman and Andrew Modlin on May 21, 1987 and is headquartered in Boca Raton, FL.

Cannabis retailer MedMen Enterprises Inc. (CSE:MMEN) (OTCQX:MMNFF) reported its consolidated financial results Thursday for its fourth quarter and for the fiscal year ended June 26, revealing a 55.4% year-over-year and 18.5% sequential increase in revenue to $42 million in the last three months of 2021. Tom Lynch, chairman and CEO of MedMen, said that the Los Angeles-based company "set a new record for quarterly revenue at MedMen, driven by broad-based increases in traffic and frequency of transactions across nearly all of our retail locations.

MedMen Reports 55% YoY Increase In Q4 2021 Revenue, Continues To Execute Its 2.0 Growth Plan After Partnering With Tilray And Serruya Private Equity

MedMen Enterprises Inc. (MMNFF) CEO Tom Lynch on Q4 2021 Results - Earnings Call Transcript

LOS ANGELES--(BUSINESS WIRE)--Fiscal Q4 and Full Year 2021 Earnings

MedMen Reports 55% Year-Over-Year Quarterly Revenue Growth and Second Consecutive Quarter of Growth in Both Revenue and Retail Adjusted EBITDA

NEW YORK & LEAMINGTON, Ontario--(BUSINESS WIRE)--Tilray, Inc. (“Tilray” or the “Company”) (NASDAQ | TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced that stockholders holding more than a majority of its issued and outstanding shares of common stock have approved an increase in the number of authorized shares of its common stock. Irwin D. Simon, Chairman and CEO, Tilray said: “We brought together Tilray and Aphria less than five months ago with

Tilray Stockholders Approve Proposal to Increase Authorized Shares at Special Meeting

LOS ANGELES--(BUSINESS WIRE)--MedMen Announces Grand Opening of Orlando, Florida, Dispensary

MedMen Announces Grand Opening of Orlando, Florida, Dispensary

LOS ANGELES--(BUSINESS WIRE)--MedMen To Announce Year Ended and Fourth Quarter Fiscal 2021 Financial Results on September 23, 2021

MedMen To Announce Year Ended and Fourth Quarter Fiscal 2021 Financial Results on September 23, 2021

Canopy Growth

Amplify Seymour Cannabis ETF

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Amplify Alternative Harvest ETF

Amplify US Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Global X Cannabis ETF

Trulieve Cannabis Corp.

AXS Cannabis ETF

Tilray Brands

Cambria Cannabis ETF

AdvisorShares Vice ETF

AdvisorShares Pure Cannabis ETF 

Waiting For The Top Down In Cannabis (Podcast)

NEW YORK & LEAMINGTON, Ontario--(BUSINESS WIRE)--Tilray, Inc. (“Tilray” or the “Company”) (NASDAQ | TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today sent an open letter to shareholders from Irwin D. Simon, Chairman and Chief Executive Officer. The letter details Mr. Simon's strategic vision and $4B revenue plan for the Company and encourages all shareholders to vote for initiatives in support of that vision and plan at Tilray's Special Meeting of Stockh

Tilray Chairman and CEO, Irwin D. Simon, Sends Shareholder Letter Mapping out $4B Revenue Plan

Pot Penny Stocks To Watch before September The post Best Cannabis Penny Stocks Under $1? 2 For Your List This Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Cannabis Penny Stocks Under $1? 2 For Your List This Week

Tilray makes its first investment in a US cannabis operator. MedMen was formerly the face of the US cannabis sector, before the stock imploded 95%.

Tilray Buys Into MedMen: What This Means For U.S. Cannabis Stocks

Tilray (TLRY) stock price predictions are of acute interest to investors right now. The stock is primed for gains with its newest purchase.

Tilray (TLRY) Stock Price Predictions: How High Can the MedMen Deal Take TLRY Stock?

Shares of Tilray Inc. rallied Wednesday, on the heels of mostly positive analyst comments on the Canadian cannabis company's announcement to buy a 21% stake in MedMen Enterprises Inc. through the purchase of notes and warrants, to increase its U.S. presence.

The Ratings Game: Analysts upbeat on Tilray's U.S. prospects after MedMen deal

Tilray (TLRY) and MedMen (MMNFF) are in the news Wednesday following the revelation that the former acquired a major stake in the latter. The post TLRY, MMNFF: 9 Things to Know About the Hot Tilray-MedMen Deal appeared first on InvestorPlace.

TLRY, MMNFF: 9 Things to Know About the Hot Tilray-MedMen Deal

MedMen Enterprises Inc. (OTCQX:MMNFF) revealed Tuesday that it has secured $100 million in financing  via a private sale of its units in a deal led by Serruya Private Equity. At the same time, the company disclosed that Tilray, Inc. (NASDAQ:TLRY) acquired the majority of MedMen's outstanding senior secured convertible notes that were originally held by certain funds affiliated with Gotham Green Partners LLC (GGP) and others.

Analyst Says MedMen's Momentum Changing, Tilray's Stake Won't Double Its Value But Will Hold Premium

MedMen runs more than 25 stores in six states, including California, the world's largest cannabis market.

Tilray jumps after $166 million deal for stake in MedMen to step into the US retail cannabis market

Cannabis retailer MedMen Enterprises Inc. (CSE:MMEN) (OTCQX:MMNFF) has secured $100 million in financing through a private placement of its units. Investors, led by Serruya Private Equity, agreed to purchase $100 million of the Los Angeles-based company's units at a purchase price of $0.24 per unit.

MedMen Announces $100M Equity Investment On Heels Of Tilray Buying Its Convertible Debt, Deal Led By Serruya Private Equity

Altria

Candian cannabis giant Tilray, Inc. (NASDAQ: TLRY) announced Tuesday it has acquired the majority of the outstanding senior secured convertible notes of MedMen Enterprises Inc. (CSE:MMEN) (OTCQX: MMNFF) that were originally held by certain funds affiliated with Gotham Green Partners, LLC and other funds. The transaction is valued at $165.8 million.

Cantor Fitzgerald Says Tilray's Stake In MedMen One Of The Steps In The 'U.S.' Journey, Could Be Getting Close To Altria

Tilray shares rose in extended trading Tuesday after it announced it acquired a majority stake in Medmen for $165.8 million.

Cannabis company Tilray acquires majority stake in Medmen in bet on U.S. legalization

Tilray, Inc. ("Tilray") (TSX:TLRY), and MedMen Enterprises Inc. ("MedMen") (CSE:MMEN) (OTCQX:MMNFF), announced on Tuesday that Tilray has acquired the majority of MedMen's outstanding senior secured convertible notes that were originally held by certain funds affiliated with Gotham Green Partners, LLC (GGP) and others. What's In It For Tilray?

Tilray Acquires Majority Position in Amended MedMen Convertible Notes, Accelerating Tilray's Path Into U.S. Cannabis Market When, Not If, Federal Legalization Occurs

Tilray Inc (NASDAQ:TLRY) shares are trading higher following news the company purchased a majority position in amended MedMen convertible notes for about $165.8 million. Irwin D. Simon, Tilray's Chairman and CEO, said, "Backed by accelerating trends towards legalization globally, we are focused on building the world's leading cannabis-focused consumer branded company with a goal of $4 billion of revenue by the end of our fiscal 2024.

Why Tilray's Stock Is Trading Higher After Hours

Canadian cannabis company Tilray Inc. has its eyes on the U.S.

Tilray eyes U.S. cannabis market with MedMen move, stock gains in late trading

LOS ANGELES--(BUSINESS WIRE)--MedMen Announces Backstopped US$100M Equity Investment Led by Serruya Private Equity to Fund Expansion and Transform Balance Sheet

MedMen Announces Backstopped US$100M Equity Investment Led by Serruya Private Equity to Fund Expansion and Transform Balance Sheet

NEW YORK & LOS ANGELES--(BUSINESS WIRE)--Tilray, Inc. (“Tilray”) (Nasdaq l TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, and MedMen Enterprises Inc. (“MedMen”) (CSE: MMEN) (OTCQX: MMNFF), a premier American cannabis retailer, today announced that Tilray has acquired the majority of the outstanding senior secured convertible notes (the “Notes”) of MedMen that were originally held by certain funds affiliated with Gotham Green Partners, LLC and other funds (c

Tilray Acquires Majority Position in Amended MedMen Convertible Notes

Are These Top Marijuana Penny Stocks Worth The Risk? The post Top Marijuana Penny Stocks For Your List In August appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Marijuana Penny Stocks For Your List In August

With as many as 219 publicly traded marijuana companies out there, finding the ones worth investing in requires knowing what to look for. The post 3 Stocks to Buy Instead of SNDL or TLRY appeared first on InvestorPlace.

News for MedMen Enterprises Inc. Stock (MMNFF)